Ultrasound Needle Guides Market
Global Ultrasound Needle Guides Market to Reach $369 Million by 2030
[London, United Kingdom] – [1st June 2023] – The global ultrasound needle guides market is projected to reach $369 million by 2030 from $274 million in 2023, at a CAGR of 6.1%. The growth of this market is mainly driven by the rising prevalence of target diseases such as cancer and cardiac disorders, increasing preference for minimally invasive biopsies, and technological advancements in ultrasound needle guides.
Reusable and disposable needle guides are the two main types of ultrasound needle guides. Reusable needle guides are made of durable materials such as stainless steel or titanium and can be used for multiple procedures. Disposable needle guides are made of plastic or other disposable materials and are used for a single procedure.
The tissue biopsy application segment is expected to be the largest segment of the ultrasound needle guides market. Tissue biopsies are used to diagnose a variety of diseases, including cancer, heart disease, and kidney disease. Ultrasound needle guides can help to improve the accuracy and safety of tissue biopsies.
The North American market is expected to be the largest market for ultrasound needle guides. The large market share of North America is attributed to the early commercialization of ultrasound needle guides in the region, the significant healthcare expenditure in the United States, and the increasing prevalence of target diseases such as cancer and cardiac disorders.
The key players in the ultrasound needle guides market include Becton, Dickinson and Company (US), Aspen Surgical (US), CIVCO Medical Solutions (US), Cook Medical (US), and Bard Access Systems (US). These companies are developing new products and technologies to improve the accuracy and safety of ultrasound needle guides.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.